To examine whether high levels of NRP2 could directly contribute to the tumorigenicity of thyroid cancer cells, we analyzed whether NRP2 downregulation, mediated by PAX8 re-expression, was able to modify the oncogenic properties of FB-2 cells. This evidence concerns the gene NRP2 and thyroid cancer.